Debut Plus

₹1,962.8

▲ +48.43 +2.53%

As of 10 Sept 2026 · delayed

NSE Listed

Emcure Pharmaceuticals Limited (EMCURE)

Volume: 2,48,776Avg Vol 1W: 1,62,485.6Avg Vol 1M: 1,31,472.5552W Range:₹1,260₹2,048
NSE BSE www.emcure.com AI Report
Key Ratios
Checked 6h ago
Market Cap₹36,566 Cr
Current Price₹1,962.8
Previous Close₹1,914.37
High / Low (52w)₹2,048 / ₹1,260
Volume2,48,776
Avg Vol (1W)1,62,485.6
Avg Vol (1M)1,31,472.55
Stock P/E64.09
Book Value₹159.61
Dividend Yield—
ROE12.8%
ROA—
Revenue (TTM)₹7,969 Cr
Revenue Growth—
Profit Margin—
Total Debt₹190 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹16.74
P/B6.72
Debt / Equity0.49
50 DMA₹1,889.12
200 DMA₹1,661.34
Day change+2.53%
Price Chart
₹1,962.8▲ 44.09% · 1Y
₹2010₹127226.8L
2025-09-10
2026-09-10

20-day avg volume: 1.3L shares

Pros
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 64.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹2,002 Cr₹1,963 Cr₹2,116 Cr₹2,101 Cr₹2,270 Cr₹2,363 Cr₹2,470 Cr₹2,580 Cr
EBITDA₹320 Cr₹262 Cr₹310 Cr₹321 Cr₹374 Cr₹390 Cr₹377 Cr₹425 Cr
Net Profit₹195 Cr₹154 Cr₹189 Cr₹207 Cr₹243 Cr₹231 Cr₹243 Cr₹294 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹1,278 Cr₹7,969 Cr₹1,097 Cr₹1,261 Cr₹1,418 Cr₹1,468 Cr₹9,335 Cr₹1,451 Cr
EBITDA₹210 Cr₹1,158 Cr₹190 Cr₹186 Cr₹377 Cr₹336 Cr₹1,462 Cr₹301 Cr
Net Profit₹140 Cr₹681 Cr₹123 Cr₹118 Cr₹259 Cr₹234 Cr₹924 Cr₹200 Cr
EPS—36.43————48.77—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹5,644 Cr₹6,004 Cr₹6,807 Cr₹6,063 Cr₹6,673 Cr₹7,806 Cr₹8,233 Cr₹9,612 Cr
Total Liabilities₹3,744 Cr₹4,020 Cr₹4,439 Cr₹3,949 Cr₹4,023 Cr₹4,684 Cr₹3,591 Cr₹4,636 Cr
Equity₹1,900 Cr₹1,984 Cr₹2,368 Cr₹2,114 Cr₹2,650 Cr₹3,122 Cr₹4,642 Cr₹4,977 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹579 Cr₹592 Cr₹905 Cr₹1,079 Cr₹947 Cr₹1,321 Cr₹1,099 Cr₹1,312 Cr
Investing₹-409 Cr₹-164 Cr₹-252 Cr₹-789 Cr₹-468 Cr₹-713 Cr₹-94 Cr₹-1,193 Cr
Financing₹-735 Cr₹-301 Cr₹-189 Cr₹-152 Cr₹-145 Cr₹-164 Cr₹-814 Cr₹343 Cr
Free Cash Flow₹579 Cr₹592 Cr₹905 Cr₹1,054 Cr₹947 Cr₹1,321 Cr₹1,099 Cr₹1,312 Cr
Shareholding
Promoter 77.83% Institutions 13.34% Public 8.83%
Efficiency & Working Capital
ROCE21.8%
Interest Coverage10
Dividend Payout—
Debtor Days102 d
Inventory Days95 d
Payable Days72 d
Cash Conversion Cycle125 d
Working Capital Days197 d
Shareholding Details

As of 2026-06-30

Promoter77.8%
FII4.9%
DII8.5%
Institutions13.3%
Public8.8%
Promoter Pledge0%
No. of Shareholders1,24,991
Shareholding Pattern

Quarterly — figures in %. Latest 10 quarters.

PeriodJul 2024Jul 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters78.1%78.1%78.1%77.9%77.9%77.9%77.9%77.9%77.9%77.8%
FIIs1.8%1.8%2.9%3%3.1%2.9%3.3%3.6%3.4%4.9%
DIIs3.3%3%4%3.9%3.4%2.8%4.4%6.1%6.1%8.5%
Public16.8%17.2%15%15.1%15.6%16.4%14.5%12.4%12.7%8.8%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%
No. of Shareholders4,98,0064,98,0061,52,9141,43,4491,39,6711,33,5491,26,1691,18,8631,22,1891,24,991
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Satish R MehtaShareholding of Promoter and Promoter Group39.8%7.54 Cr
Everest Trust (shares Held By Sanjay Rajanikant Mehta With Sonali Sanjay Mehta, As Trustees)Shareholding of Promoter and Promoter Group7.7%1.45 Cr
Unity Trust (shares Held By Sunil Rajanikant Mehta With Kamini Sunil Mehta, As Trustees)Shareholding of Promoter and Promoter Group7.7%1.45 Cr
Samit Satish MehtaShareholding of Promoter and Promoter Group7.1%1.35 Cr
Bhavana Satish MehtaShareholding of Promoter and Promoter Group4.7%89,16,888
Namita Vikas ThaparShareholding of Promoter and Promoter Group2.7%50,71,200
Pushpa Rajnikant MehtaShareholding of Promoter and Promoter Group2.1%38,86,052
Sanjay Rajanikant MehtaShareholding of Promoter and Promoter Group2%37,04,028
Kotak Midcap FundPublic Shareholding1.9%36,55,995
Sunil Rajanikant MehtaShareholding of Promoter and Promoter Group1.5%28,47,012
Aditya Birla Sun Life Trustee Private Limited A/c - Aditya Birla Sun Life Elss Tax Saver FundPublic Shareholding1.4%27,25,251
Nippon Life India Trustee Ltd-a/c Nippon India Multi Cap FundPublic Shareholding1.3%25,29,948
Government Pension Fund GlobalPublic Shareholding1.1%20,00,000
Hdfc Life Insurance Company LimitedPublic Shareholding1%19,45,593
Kamini Sunil MehtaShareholding of Promoter and Promoter Group0.9%16,64,960
Niraj Sunil MehtaShareholding of Promoter and Promoter Group0.6%11,00,000
Rutav Sunil MehtaShareholding of Promoter and Promoter Group0.5%9,88,224
Vikas M ThaparShareholding of Promoter and Promoter Group0.3%6,45,000
Surekha Umakant ShahShareholding of Promoter and Promoter Group0.2%3,18,216
Shah Suhasini SaumilShareholding of Promoter and Promoter Group0.1%1,29,216
Smita Paresh ShahShareholding of Promoter and Promoter Group0.1%1,07,458
Girishchandr Harrai Maganlal DesaiShareholding of Promoter and Promoter Group0.1%1,15,716
Shaila Sharad GujarShareholding of Promoter and Promoter Group0%78,206
Swati Hetalkumar ShahShareholding of Promoter and Promoter Group0%64,716
Ranjanakumari Mukeshbhai DesaiShareholding of Promoter and Promoter Group0%28,928
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Smita Paresh Shah60,00055.8%2026-06-30
Board of Directors
NameDesignationYear
MUKUND KESHAO GURJARWhole Time Director2025
SATISH RAMANLAL MEHTACMD & CEO2025
NAMITA VIKAS THAPARWhole-time Director2025
SAMIT SATISH MEHTAWhole Time Director & COO2025
Vidya Rajiv YeravdekarIndependent Director2025
Vijay GokhaleIndependent Director2025
Shailesh AyyangarIndependent Director2025
Samonnoi BanerjeeNon Executive Director2025
Amruta Jana YangalwarCompany Sec. & Compli. Officer2025
RAMAN PILLAI RAGHU KUMARAdditional Director2025
Segments — Product
SegmentRevenueShare
Pharmaceutical Products₹0 Cr—
Segments — Geography
RegionRevenueShare
Within India₹2,608 Cr49.7%
Europe₹773 Cr14.8%
North America₹342 Cr6.5%
Other continents₹1,520 Cr29%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10250190190
Corporate Actions
TypeDateValueRemark
forthcoming2026-09-04Dividend (3.6/- per share)Final
forthcoming2026-09-04Dividend—
dividend2026-09-04₹3.6 (36%)Final
forthcoming2026-08-06Board Meetings—
dividend2025-08-14₹3 (30%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20253,38000934463,918
20251,03400001,034
2025000202
Company Information
Incorporated1981
ChairmanSATISH RAMANLAL MEHTA
AuditorBSR & Co LLP
Investor Email[email protected]
🌐 www.emcure.com ↗

📍 Plot # P-1 & P-2 IT BT Park, Phase II MIDC Hinjawadi, Pune, Maharashtra, 411057

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Emami LimitedEmami Paper MillsEmami Realty LimitedEMA Partners India Ltd.Embassy Office Parks REITEmbassy Developments Ltd.Electronics Mart India Ltd.Emkay Global Financial Services Ltd.Emkay Taps & Cutting Tools Ltd.Emmbi Industries LimitedEnergy-Mission Machineries (India) Ltd.Emmvee Photovoltaic Pwr LimitedAll “E” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search